Growing evidence suggests that LPCAT3 is critically involved in the development of several pathologies that include skeletal muscle myopathy [30], atherosclerosis [31], acute kidney disease [32], nonalcoholic steatohepatitis [31], hyperuricemia [33], cancer [34], and other metabolic diseases. The gene discussed is LPCAT3; the disease is atherosclerosis.